000 | 01417 a2200385 4500 | ||
---|---|---|---|
005 | 20250518043247.0 | ||
264 | 0 | _c20200127 | |
008 | 202001s 0 0 eng d | ||
022 | _a1365-4632 | ||
024 | 7 |
_a10.1111/ijd.14542 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Xiran | |
245 | 0 | 0 |
_aProgrammed cell death protein 1 and vitiligo. _h[electronic resource] |
260 |
_bInternational journal of dermatology _cSep 2019 |
||
300 |
_a1102-1103 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aB7-H1 Antigen _xgenetics |
650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
650 | 0 | 4 |
_aMelanocytes _xdrug effects |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Ligand 2 Protein _ximmunology |
650 | 0 | 4 |
_aProgrammed Cell Death 1 Receptor _xagonists |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSkin _xcytology |
650 | 0 | 4 |
_aSkin Pigmentation _xdrug effects |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
650 | 0 | 4 |
_aVitiligo _xdrug therapy |
700 | 1 | _aMeng, Xianmin | |
700 | 1 | _aSong, Zhiqi | |
773 | 0 |
_tInternational journal of dermatology _gvol. 58 _gno. 9 _gp. 1102-1103 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ijd.14542 _zAvailable from publisher's website |
999 |
_c29775488 _d29775488 |